Literature DB >> 33308170

The diagnostic accuracy of direct agglutination test for serodiagnosis of human visceral leishmaniasis: a systematic review with meta-analysis.

Mehdi Mohebali1,2, Hossein Keshavarz1,2, Sedigheh Shirmohammad2, Behnaz Akhoundi1, Alireza Borjian1, Gholamreza Hassanpour2, Setareh Mamishi3, Shima Mahmoudi4.   

Abstract

BACKGROUND: Direct agglutination test (DAT) as a simple, accurate and reliable method, has been widely used for serodiagnosis of visceral leishmaniasis (VL) during the last three decades. The present study is a systematic review and meta-analysis to evaluate the diagnostic accuracy of DAT for serodiagnosis of human VL.
METHODS: Electronic databases, including MEDLINE (via PubMed), SCOPUS, Web of Science, SID and Mag Iran (two Persian scientific search engines) were searched from December 2004 to April 2019. We determined the pooled sensitivity and specificity rates of DAT for the diagnosis of human VL, calculated positive and negative likelihood ratios (LR+ and LR-), and constructed summary receiver operating characteristic (ROC) curves parameters across the eligible studies.
RESULTS: Of the 2928 records identified in the mentioned electronic databases and after examining reference lists of articles, 24 articles met inclusion criteria and were enrolled in the systematic review and out of them 20 records qualified for meta-analysis. The pooled sensitivity and specificity rates of DAT was 96% [95% CI, 92-98] and 95% [CI95% 86-99], respectively. The likelihood ratio of a positive test (LR+) was found to be 21 [CI95%, 6.6-66.5] and the likelihood ratio of a negative test (LR-) was found to be 0.04 [(CI95%, 0.02-0.08]. The combined estimate of the diagnostic odds ratio for DAT was high [467 (CI95%, 114-1912]). We found that the summary receiver operating characteristic curve (SROC) is positioned near the upper left corner of the curve and the area under curve (AUC) was 0.98 (95% CI, 0.97 to 0.99).
CONCLUSION: Referring to our analysis, we determined that DAT can be considered as a valuable tool for the serodiagnosis of human VL with high sensitivity and specificity. As DAT is a simple, accurate and efficient serological test, it can be recommended for serodiagnosis of human VL particularly in endemic areas.

Entities:  

Keywords:  Diagnostic accuracy; Direct agglutination test; Human; Meta- analysis; Systematic review; Visceral leishmaniasis

Year:  2020        PMID: 33308170     DOI: 10.1186/s12879-020-05558-7

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  35 in total

1.  The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

Authors:  Jonathan J Deeks; Petra Macaskill; Les Irwig
Journal:  J Clin Epidemiol       Date:  2005-09       Impact factor: 6.437

Review 2.  A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis.

Authors:  François Chappuis; Suman Rijal; Alonso Soto; Joris Menten; Marleen Boelaert
Journal:  BMJ       Date:  2006-08-01

3.  Evaluation of a glycerol-preserved antigen in the direct agglutination test for diagnosis of visceral leishmaniasis at rural level in eastern Sudan.

Authors:  Mohamed El Mutasim; Durria Mansour; Elfadil M Abass; Wisam M Hassan; Abdallah El Harith
Journal:  J Med Microbiol       Date:  2006-10       Impact factor: 2.472

4.  Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study.

Authors:  S Bimal; V N R Das; P K Sinha; A K Gupta; N Verma; A Ranjan; S K Singh; A Sen; S K Bhattacharya; P Das
Journal:  Ann Trop Med Parasitol       Date:  2005-12

5.  Pre- and post-treatment antibody levels in visceral leishmaniasis.

Authors:  A Hailu
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

6.  Practical approach for typing strains of Leishmania infantum by enzyme polymorphism: a cross sectional study in Northwest of Iran.

Authors:  A S Mazloumi Gavgani; A Ghazanchaei; P Karimi; H Mohit; C R Davies
Journal:  Pak J Biol Sci       Date:  2007-12-15

Review 7.  Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy.

Authors:  C M de Ruiter; C van der Veer; M M G Leeflang; S Deborggraeve; C Lucas; E R Adams
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

8.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Application of direct agglutination test (DAT) and fast agglutination screening test (FAST) for sero-diagnosis of visceral leishmaniasis in endemic area of Minas Gerais, Brazil.

Authors:  Eduardo S Silva; Gerard J Schoone; Celia M F Gontijo; Reginaldo P Brazil; Raquel S Pacheco; Henk D F H Schallig
Journal:  Kinetoplastid Biol Dis       Date:  2005-06-14

10.  The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.

Authors:  Penny Whiting; Anne W S Rutjes; Johannes B Reitsma; Patrick M M Bossuyt; Jos Kleijnen
Journal:  BMC Med Res Methodol       Date:  2003-11-10       Impact factor: 4.615

View more
  5 in total

1.  Mediterranean visceral leishmaniasis : update on biological diagnosis.

Authors:  Emna Siala; Aida Bouratbine; Karim Aoun
Journal:  Tunis Med       Date:  2022 Janvier

2.  ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.

Authors:  Nathalia C Galvani; Amanda S Machado; Daniela P Lage; Camila S Freitas; Danniele L Vale; Daysiane de Oliveira; Fernanda Ludolf; Fernanda F Ramos; Bruna B Fernandes; Gabriel P Luiz; Débora V C Mendonça; João A Oliveira-da-Silva; Thiago A R Reis; Grasiele S V Tavares; Ana T Chaves; Nathalia S Guimarães; Unaí Tupinambás; Gláucia F Cota; Maria V Humbert; Vívian T Martins; Myron Christodoulides; Eduardo A F Coelho; Ricardo A Machado-de-Ávila
Journal:  Parasitol Res       Date:  2021-10-19       Impact factor: 2.289

3.  Validation of a mixture of rK26 and rK39 antigens from Iranian strain of Leishmania infantum to detect anti-Leishmania antibodies in human and reservoir hosts.

Authors:  Bibi Razieh Hosseini Farash; Mehdi Mohebali; Bahram Kazemi; Abdolmajid Fata; Homa Hajjaran; Behnaz Akhoundi; Reza Raoofian; Pietro Mastroeni; Elham Moghaddas; Azad Khaledi; Ghodratollah Salehi Sangani
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 4.  Evidence map of diagnosis, treatment, prognosis, prevention, and control in visceral leishmaniasis.

Authors:  Andressa Barros Ibiapina; Francisca Miriane de Araújo Batista; Bruno Guedes Alcoforado Aguiar; Vagner José Mendonça; Dorcas Lamounier Costa; Carlos Henrique Nery Costa; Carmen Verônica Mendes Abdala
Journal:  Rev Panam Salud Publica       Date:  2022-07-20

5.  Molecular and serological evaluation of visceral leishmaniasis in domestic dogs and cats in Maragheh County, north-west of Iran, 2018-2021.

Authors:  Ali Soleimani; Mehdi Mohebali; Saber Gholizadeh; Arezoo Bozorgomid; Reza Shafiei; Saber Raeghi
Journal:  Vet Med Sci       Date:  2022-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.